Exhibit 99.1
INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
INTERIM CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2023
UNAUDITED
INDEX
Page | ||
F-2 - F-3 | ||
F-4 | ||
F-5 | ||
F-6 - F-7 | ||
F-8 - F-16 |
- - - - - - - - - - -
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Short term restricted cash
|
|
|
||||||
Bank deposits
|
|
|
||||||
Marketable securities
|
|
|
||||||
Trade receivables, net
|
|
|
||||||
Inventory
|
|
|
||||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
|
|
||||||
Restricted deposits
|
|
|
||||||
Property and equipment, net
|
|
|
||||||
Operating lease right-of-use assets, net
|
|
|
||||||
Other long-term assets
|
|
|
||||||
Total long-term assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
|
$
|
|
||||
Advances from customers and deferred revenues
|
|
|
||||||
Employees and payroll accruals
|
|
|
||||||
Accrued expenses and other current liabilities
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Advances from customers and deferred revenues
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Warrants liability
|
|
|
||||||
Total long-term liabilities
|
|
|
||||||
SHAREHOLDERS' EQUITY:
|
||||||||
Ordinary Shares of
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
Total shareholders' equity
|
|
|
||||||
Total liabilities and shareholders' equity
|
$
|
|
$
|
|
Six Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Revenues
|
$
|
|
$
|
|
||||
Cost of revenues
|
(
|
)
|
(
|
)
|
||||
Gross loss
|
(
|
)
|
(
|
)
|
||||
Operating expenses:
|
||||||||
Research and development
|
|
|
||||||
Sales and marketing
|
|
|
||||||
General and administrative
|
|
|
||||||
Total operating expenses
|
|
|
||||||
Operating loss
|
(
|
)
|
(
|
)
|
||||
Financial income, net
|
|
|
||||||
Loss before taxes on income
|
(
|
)
|
(
|
)
|
||||
Taxes on income
|
(
|
)
|
(
|
)
|
||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Basic and diluted net loss per ordinary share
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
|
|
|
|
Ordinary Shares
|
Additional
Paid-in Capital
|
Accumulated
Deficit
|
Total
Shareholders’ Equity |
|||||||||||||||
|
Number
|
Amount
|
|||||||||||||||||
Balance as of December 31, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
Reclassification of warrants liability to equity |
- | ||||||||||||||||||
Exercise of shares options
|
|
|
|
|
|
||||||||||||||
Exercise of public warrants |
|
||||||||||||||||||
Vesting of RSUs
|
|
|
|
|
|||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
||||||||||||||
Net Loss
|
-
|
|
|
(
|
)
|
(
|
)
|
||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
Balance as of December 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
Reclassification of warrants liability to equity
|
-
|
|
|
|
|
||||||||||||||
Exercise of shares options
|
|
|
|
|
|
||||||||||||||
Vesting of RSUs
|
|
|
|
|
|
||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
||||||||||||||
Net Loss
|
-
|
|
|
(
|
)
|
(
|
)
|
||||||||||||
|
|||||||||||||||||||
Balance as of June 30, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
The accompanying notes are an integral part of the interim consolidated financial statements.
Six Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Cash Flows from Operating Activities:
|
||||||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Adjustments required to reconcile net loss to net cash used in Operating Activities:
|
||||||||
Depreciation and amortization
|
|
|
||||||
Remeasurement of warrants liability
|
(
|
)
|
(
|
)
|
||||
Change in accrued interest on bank deposits
|
|
(
|
)
|
|||||
Change in marketable securities
|
(
|
)
|
|
|||||
Share-based compensation
|
|
|
||||||
Foreign exchange loss, net
|
|
|
||||||
Change in prepaid expenses and other assets
|
|
(
|
)
|
|||||
Change in trade receivables, net
|
(
|
)
|
(
|
)
|
||||
Change in inventory
|
(
|
)
|
(
|
)
|
||||
Changes in operating lease assets and liabilities, net
|
|
(
|
)
|
|||||
Change in trade payables
|
(
|
)
|
|
|||||
Change in accrued expenses and other liabilities
|
|
(
|
)
|
|||||
Change in employees and payroll accruals
|
|
(
|
)
|
|||||
Change in advances from customers and deferred revenues
|
|
|
||||||
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
Cash flows from investing activities:
|
||||||||
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
Investment in bank deposits
|
(
|
)
|
(
|
)
|
||||
Withdrawal of bank deposits
|
|
|
||||||
Increase in restricted deposits
|
(
|
)
|
(
|
)
|
||||
Investment in marketable securities
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales and maturities of marketable securities
|
|
|
||||||
Net cash provided by investing activities
|
$
|
|
$
|
|
|
Six Months Ended
June 30,
|
|||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Cash flows from financing activities:
|
||||||||
Proceeds from exercise of options
|
|
|
||||||
Net cash provided by financing activities
|
|
|
||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
(
|
)
|
|
|||||
Cash, cash equivalents and restricted cash at the beginning of the period
|
|
|
||||||
Cash, cash equivalents and restricted cash at the end of the period
|
$
|
|
$
|
|
||||
Supplementary disclosure of cash flows activities:
|
||||||||
(1) Cash paid during the period for:
|
||||||||
Income taxes
|
$
|
|
$
|
|
||||
(2) Non-cash transactions:
|
||||||||
Purchase of property and equipment
|
$
|
|
$
|
|
||||
Reclassification of warrants liability to equity
|
$ | $ | ||||||
Exercise of options
|
$ |
$ |
||||||
Right-of-use assets recognized with corresponding lease liabilities
|
$
|
|
$
|
|
||||
(3) Cash, cash equivalents and restricted cash at the end of the period:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Short-term restricted cash
|
||||||||
$
|
|
$
|
|
a. |
Innoviz Technologies Ltd. and its subsidiaries (the “Company” or “Innoviz”) is a Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The Company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, as well as other industries that require 3-dimensional high-resolution sensors. In addition, Innoviz’ solutions can enable safe autonomy for other industries, including logistics, drones, robotics, construction and other industrial applications, smart city, smart infrastructures and mapping.
|
b. |
The Company was incorporated on January 18, 2016, under the laws of the state of Israel.
|
c. |
On December 10, 2020, the Company entered into definitive agreements in connection with a merger (the “Transactions”) with Collective Growth Corporation (“Collective Growth”), a special purpose acquisition company, that resulted in Collective Growth becoming a wholly owned subsidiary of the Company upon the consummation of the Transactions on April 5, 2021 (the “Closing Date”).
|
d. |
As of June 30, 2023, the Company’s principal source of liquidity includes its cash and cash equivalents in the amount of $
|
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES
|
a. |
Interim Financial Statements
|
b. |
Significant accounting policies
|
F - 8
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
c. | Use of estimates: |
d. |
Concentration of credit risk:
|
e. |
Recently adopted accounting pronouncement:
|
F - 9
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 3:- |
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS |
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Contract liabilities, Current
|
||||||||
Deferred revenues
|
$
|
|
$
|
|
||||
Advances from customers
|
|
|
||||||
Total
|
$
|
|
$
|
|
||||
Contract liabilities, Long-term
|
||||||||
Deferred revenues
|
$
|
|
$
|
|
||||
Total Contract liabilities
|
$
|
|
$
|
|
F - 10
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 4:- |
FAIR VALUE MEASUREMENTS |
June 30, 2023
|
||||||||||||||||
(Unaudited)
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Assets:
|
||||||||||||||||
Marketable securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
||||||||||||||||
Total financial assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities:
|
||||||||||||||||
Warrants (1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Total financial liabilities
|
$
|
|
$
|
|
$
|
|
$
|
|
December 31, 2022
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Assets:
|
||||||||||||||||
Marketable securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
||||||||||||||||
Total financial assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities:
|
||||||||||||||||
Warrants (1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Total financial liabilities
|
$
|
|
$
|
|
$
|
|
$
|
|
(1) |
As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net.
|
F - 11
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 4:- |
FAIR VALUE MEASUREMENTS (Cont.) |
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Balance as of January 1
|
$
|
|
$
|
|
||||
Change in fair value of warrants liability
|
(
|
)
|
(
|
)
|
||||
Reclassification of warrants liability to equity
|
(
|
)
|
(
|
)
|
||||
Balance as of June 30
|
$
|
|
$
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Fair value determined per warrant
|
$
|
|
$
|
|
||||
Expected volatility
|
|
%
|
|
%
|
||||
Expected annual dividend yield
|
|
%
|
|
%
|
||||
Expected term (years)
|
|
|
||||||
Risk-free rate
|
|
%
|
|
%
|
NOTE 5:- |
LEASES |
Operating lease right-of-use assets, net
|
$
|
|
||
|
||||
Operating lease liabilities, current
|
$
|
|
||
Operating lease liabilities, non-current
|
|
|||
|
||||
Total operating lease liabilities
|
$
|
|
||
Weighted average remaining lease term (years)
|
|
|||
Weighted average discount rate of operating leases
|
|
%
|
F - 12
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 5:- |
LEASES (Cont.) |
Six Months Ended
June 30, 2023
(unaudited)
|
||||
Operating lease costs
|
$
|
|
||
Variable lease payments
|
$
|
|
||
Short term lease costs
|
$
|
|
||
Operating cash flows from lease incentives received, net of cash paid for operating leases
|
$
|
|
Year Ended December 31, (unaudited)
|
||||
2023
|
$
|
|
||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
Thereafter
|
|
|||
|
||||
Total undiscounted lease payments
|
$
|
|
||
|
||||
Less: interest
|
(
|
)
|
||
|
||||
Present value of lease liabilities
|
$
|
|
NOTE 6:- |
COMMITMENTS AND CONTINGENCIES
|
F - 13
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 7:- |
SHARE-BASED COMPENSATION
|
a. |
Options granted:
|
Number of options
|
Weighted-average exercise price
|
Weighted- average
remaining contractual term (in years) |
Aggregate intrinsic value
|
|||||||||||||
Outstanding as of December 31, 2022
|
|
$
|
|
|
$
|
|
||||||||||
Granted
|
|
$ |
|
|
||||||||||||
Exercised
|
(
|
)
|
$ |
|
$ |
|
||||||||||
Forfeited
|
(
|
)
|
$ |
|
$ |
|
||||||||||
Expired
|
(
|
)
|
$ |
|
|
|||||||||||
Outstanding as of June 30, 2023
|
|
$
|
|
|
$
|
|
||||||||||
Exercisable as of June 30, 2023
|
|
$
|
|
|
$
|
|
b. |
RSUs granted:
|
Number of
shares
|
Weighted
average grant date fair value per share |
|||||||
Unvested as of December 31, 2022
|
|
$
|
|
|||||
Granted
|
|
$ |
|
|||||
Vested
|
(
|
)
|
$ |
|
||||
Forfeited
|
(
|
)
|
$ |
|
||||
Unvested as of June 30, 2023
|
|
$
|
|
F - 14
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 7:- |
SHARE-BASED COMPENSATION (Cont.)
|
c. |
Share-based compensation expenses:
|
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Cost of revenues
|
$
|
|
$
|
|
||||
Research and development
|
|
|
||||||
Sales and marketing
|
|
|
||||||
General and administrative
|
|
|
||||||
$
|
|
$
|
|
NOTE 8:- |
BASIC AND DILUTED NET LOSS PER SHARE
|
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Numerator:
|
||||||||
Net Loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Denominator:
|
||||||||
|
||||||||
|
|
a. |
|
b. |
|
F - 15
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)
NOTE 9:- |
GEOGRAPHIC AND CUSTOMER INFORMATION |
a. |
Geographic information:
|
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Europe, Middle East and Africa (*)
|
$
|
|
$
|
|
||||
Asia Pacific
|
|
|
||||||
North America (**)
|
|
|
||||||
$
|
|
$
|
|
(*) |
Includes revenue from Germany in the amount of $
|
(**) |
Includes revenues from United States only.
|
b. |
Customers accounted for over 10% of revenue:
|
F - 16